bf/NASDAQ:SPRO_icon.jpeg

NASDAQ:SPRO

Spero Therapeutics

  • Stock

USD

Last Close

1.37

30/08 20:00

Market Cap

73.42M

Beta: 0.87

Volume Today

58.38K

Avg: 603.93K

PE Ratio

−115.83

PFCF: 2.64

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.02
-
0.02
12.97%
0.03
45.21%
0.04
45.38%
0.06
36.04%
0.11
75.52%
0.39
264.75%
0.53
36.26%
cash conversion cycle
-1.18K
-
cash per share
0.86
-
1.56
81.25%
33.74
2,060.59%
7.21
78.62%
4.52
37.38%
5.67
25.48%
4.74
16.41%
2.90
38.74%
1.45
50.11%
company equity multiplier
36.61
-
1.35
96.30%
1.10
18.76%
1.11
1.20%
1.42
27.77%
1.16
18.32%
1.94
66.73%
1.64
15.18%
1.71
3.82%
days of inventory outstanding
days of payables outstanding
1.37K
-
days of sales outstanding
331.22
-
542.80
63.88%
119.46
77.99%
657.80
450.65%
241.61
63.27%
52.80
78.15%
8.14
84.58%
191.29
2,248.65%
dividend yield
ebit per revenue
-99.17
-
-21.09
78.74%
-10.79
48.81%
-13.33
23.51%
-8.48
36.39%
-4.82
43.17%
-0.87
81.97%
0.20
123.49%
ebt per ebit
0.99
-
0.98
0.45%
1.10
12.43%
0.97
11.89%
0.96
0.98%
0.99
2.67%
1.02
3.11%
1.10
7.81%
1.29
16.99%
effective tax rate
0.24
-
0.24
1.83%
0.01
96.67%
-0.03
448.70%
0.01
144.83%
0.01
21.03%
-0.02
277.06%
-0.03
101.89%
0.10
394.28%
enterprise value multiple
-5.21
-
-1.96
62.41%
1.36
169.62%
-1.50
210.23%
-2.38
58.43%
-4.51
89.36%
-4.46
1.16%
1.98
144.36%
0.33
83.19%
fixed asset turnover
0.22
-
1.70
661.27%
1.37
19.37%
0.66
51.61%
1.06
60.13%
2.42
127.44%
8.85
266.10%
23.27
163.08%
free cash flow per share
-1.49
-
-4.51
202.73%
-15.13
235.45%
-2.63
82.63%
-2.77
5.44%
-3.84
38.65%
-2.08
45.84%
-0.21
90.12%
-0.63
204.36%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1.00
0.38%
interest coverage
-137.72
-
-141.27
2.58%
-45.35
-
-16.20
64.28%
inventory turnover
long term debt to capitalization
0.06
-
0.05
14.93%
0.06
27.75%
0.06
3.29%
0.03
43.62%
net income per ebt
0.77
-
0.78
1.16%
1
28.05%
1
0%
0.99
1.23%
0.99
0.26%
1.02
2.72%
1.03
1.72%
0.90
13.24%
net profit margin
-76.09
-
-23.29
69.39%
-10.50
54.90%
-12.69
20.80%
-8.31
34.53%
-5.00
39.81%
-0.99
80.23%
0.24
123.85%
operating cash flow per share
-1.45
-
-4.38
201.41%
-15.12
244.83%
-2.48
83.62%
-2.75
11.23%
-3.84
39.27%
-2.08
45.71%
-0.21
90.12%
-0.63
204.36%
operating cycle
191.29
-
operating profit margin
-99.17
-
-21.09
78.74%
-10.79
48.81%
-13.33
23.51%
-8.48
36.39%
-4.82
43.17%
-0.87
81.97%
0.20
123.49%
payables turnover
0.27
-
pretax profit margin
-97.44
-
-23.29
76.09%
-10.50
54.90%
-12.85
22.31%
-8.39
34.70%
-4.92
41.40%
-0.96
80.57%
0.26
127.49%
price fair value
387.53
-
7.47
98.07%
0.36
95.21%
0.85
137.42%
2.34
175.79%
3.29
40.33%
5.60
70.42%
0.86
84.72%
0.72
15.36%
receivables turnover
1.10
-
0.67
38.98%
3.06
354.38%
0.55
81.84%
1.51
172.25%
6.91
357.58%
44.81
548.31%
1.91
95.74%
return on assets
-1.41
-
-1.85
30.81%
-0.49
73.36%
-0.32
34.51%
-0.57
75.61%
-0.51
10.93%
-0.53
5.65%
-0.38
27.89%
0.13
132.49%
return on capital employed
-17.65
-
-4.85
72.54%
-0.49
89.91%
-0.37
24.99%
-0.80
116.92%
-0.57
28.53%
-0.58
1.50%
-0.41
29.13%
0.14
133.23%
return on equity
-51.81
-
-2.51
95.16%
-0.54
78.35%
-0.36
33.72%
-0.81
124.39%
-0.59
27.24%
-1.03
76.14%
-0.63
38.84%
0.21
133.73%
total debt to capitalization
0.79
-
0.07
-
0.06
19.04%
0.08
36.89%
0.08
4.93%
0.05
38.75%

All numbers in USD (except ratios and percentages)